← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:288 | 288 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-106 | 71449-106-11 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:288 | 288 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6632 | 71300-6632-1 | Diclofenac Sodium | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:288 | 288 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:288 | 288 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-976 | 69194-976-10 | Epinephrine | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:288 | 288 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-060 | 71506-060-58 | Epinephrine | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:288 | 288 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-127 | 82396-127-10 | Esmolol Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:288 | 288 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-375 | 73693-375-01 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:289 | 289 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0125 | 73271-0125-1 | ESTRADIOL 12.5 PEL | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:289 | 289 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:289 | 289 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:289 | 289 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexamethasone Sodium Phosphate; Moxifloxacin Hydrochloride; Ketorolac Tromethamine | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:289 | 289 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:289 | 289 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Chlorambucil | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:289 | 289 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0859 | 5446-0859-03 | Cyclopentolate Hydrochloride; Phenylephrine Hydrochloride; Tropicamide; Ketorolac Tromethamine | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:289 | 289 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8093 | 72196-8093-1 | Epinephrine | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:289 | 289 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:289 | 289 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-106 | 71449-106-15 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:289 | 289 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5579 | 26436-5579-1 | Diclofenac Sodium | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:289 | 289 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:289 | 289 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-975 | 69194-975-10 | Epinephrine | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:289 | 289 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:289 | 289 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0025 | 73271-0025-1 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:289 | 289 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3720 | 72682-3720-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:290 | 290 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-546 | 70092-546-35 | Hydromorph PF 1 mg/ml in 50 ml NS IVB | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:290 | 290 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:290 | 290 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:290 | 290 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-109 | 71449-109-11 | Dexmedetomidine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:290 | 290 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:290 | 290 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Chloramphenicol | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:290 | 290 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0993 | 5446-0993-01 | Cyclopentolate Hydrochloride; Phenylephrine Hydrochloride; Tropicamide; Ketorolac Tromethamine | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:290 | 290 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-060 | 71506-060-58 | Epinephrine | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:290 | 290 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:290 | 290 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:290 | 290 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1338 | 72934-1338-2 | Diclofenac Sodium; Niacinamide | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:290 | 290 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:290 | 290 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:290 | 290 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:290 | 290 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0006 | 73271-0006-1 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:290 | 290 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3712 | 72682-3712-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:291 | 291 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-023 | 73198-023-03 | SB-4 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:291 | 291 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:291 | 291 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:291 | 291 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-108 | 71449-108-11 | Dexmedetomidine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:291 | 291 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:291 | 291 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2433 | 72627-2433-3 | Cholecalciferol | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:291 | 291 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-092 | 71449-092-45 | Cyclopentolate Hydrochloride; Tropicamide; Phenylephrine Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:291 | 291 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7018 | 72196-7018-1 | Epinephrine | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:291 | 291 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6624 | 71300-6624-2 | Epinephrine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:291 | 291 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-605 | 70004-605-09 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:291 | 291 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diltiazem Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:291 | 291 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-106 | 71449-106-15 | Ephedrine Sulfate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:291 | 291 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-060 | 71506-060-58 | Epinephrine | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:291 | 291 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-164 | 73177-164-03 | Epinephrine Bitartrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:291 | 291 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0018 | 73271-0018-1 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:291 | 291 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3715 | 72682-3715-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:292 | 292 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0006 | 81483-0006-0 | Ketamine 10mg/mL. 5mL | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:292 | 292 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:292 | 292 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0409 | 71285-0409-1 | Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:292 | 292 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-131 | 71449-131-18 | Dexmedetomidine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:292 | 292 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:292 | 292 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5559 | 26436-5559-3 | Choline Chloride; Lidocaine Hydrochloride Anhydrous; Niacinamide; Thiamine Hydrochloride; Arginine; Methionine; Inositol; Carnitine; Pyridoxine Hydrochloride | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:292 | 292 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-092 | 71449-092-46 | Cyclopentolate Hydrochloride; Tropicamide; Phenylephrine Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:292 | 292 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7019 | 72196-7019-1 | Epinephrine | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:292 | 292 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7018 | 71285-7018-1 | Epinephrine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:292 | 292 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-604 | 70004-604-12 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:292 | 292 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diltiazem Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:292 | 292 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-106 | 71449-106-11 | Ephedrine Sulfate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:292 | 292 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-977 | 69194-977-10 | Epinephrine | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:292 | 292 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0036 | 81483-0036-0 | Epinephrine Bitartrate; Bupivacaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:292 | 292 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0010 | 73271-0010-1 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:292 | 292 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3725 | 72682-3725-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:293 | 293 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-070 | 71449-070-25 | Ropivacaine Hydrochloride | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:293 | 293 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4837 | 61141-4837-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:293 | 293 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0848 | 5446-0848-01 | Dexamethasone | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:293 | 293 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-131 | 71449-131-11 | Dexmedetomidine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:293 | 293 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine; Tacrolimus | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:293 | 293 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Choline Chloride; Methionine; Inositol; Cyanocobalamin | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:293 | 293 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclophosphamide | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:293 | 293 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7018 | 71285-7018-1 | Epinephrine | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:293 | 293 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7019 | 71285-7019-1 | Epinephrine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:293 | 293 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-604 | 70004-604-09 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:293 | 293 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diltiazem Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:293 | 293 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9035 | 71266-9035-9 | Ephedrine Sulfate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:293 | 293 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:293 | 293 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-121 | 73177-121-19 | Epinephrine Bitartrate; Tetracaine Hydrochloride; Lidocaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:293 | 293 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0125 | 73271-0125-1 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:293 | 293 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3710 | 72682-3710-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:294 | 294 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6527 | 72934-6527-2 | Mythius | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:294 | 294 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:294 | 294 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0622 | 5446-0622-01 | Dexamethasone | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:294 | 294 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexmedetomidine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:294 | 294 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Demecarium Bromide | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:294 | 294 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cidofovir Anhydrous | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:294 | 294 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclophosphamide | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:294 | 294 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7019 | 71285-7019-1 | Epinephrine | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:294 | 294 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8093 | 71285-8093-1 | Epinephrine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:294 | 294 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6003 | 71286-6003-2 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:294 | 294 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-575 | 70092-575-36 | Diltiazem Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:294 | 294 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9045 | 71266-9045-5 | Ephedrine Sulfate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:294 | 294 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:294 | 294 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-134 | 71449-134-24 | Epinephrine; Bupivacaine Hydrochloride; Dexamethasone Sodium Phosphate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:294 | 294 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0375 | 73271-0375-1 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:294 | 294 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3706 | 72682-3706-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:295 | 295 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1592 | 72934-1592-2 | Aluxof | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:295 | 295 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:295 | 295 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-776 | 69852-776-10 | Dexamethasone Acetate Anhydrous | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:295 | 295 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-108 | 71449-108-18 | Dexmedetomidine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:295 | 295 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Demecarium Bromide | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:295 | 295 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cisapride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:295 | 295 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclophosphamide | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:295 | 295 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8110 | 71266-8110-1 | Epinephrine | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:295 | 295 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-812 | 76154-812-15 | Epinephrine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:295 | 295 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6004 | 71286-6004-1 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:295 | 295 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6054 | 72196-6054-1 | Diltiazem Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:295 | 295 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9027 | 71266-9027-1 | Ephedrine Sulfate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:295 | 295 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6624 | 71300-6624-2 | Epinephrine | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:295 | 295 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Lidocaine | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:295 | 295 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0015 | 73271-0015-1 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:295 | 295 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-378 | 73693-378-01 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:296 | 296 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2546 | 72934-2546-2 | Sorixia | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:296 | 296 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:296 | 296 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1050 | 71266-1050-2 | Dexamethasone Sodium Phosphate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:296 | 296 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexpanthenol | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:296 | 296 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0848 | 5446-0848-01 | Dexamethasone | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:296 | 296 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cisapride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:296 | 296 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclophosphamide | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:296 | 296 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-925 | 69374-925-10 | Epinephrine | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:296 | 296 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-813 | 76154-813-15 | Epinephrine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:296 | 296 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-107 | 73702-107-15 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:296 | 296 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6055 | 72196-6055-1 | Diltiazem Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:296 | 296 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6624 | 71300-6624-2 | Epinephrine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:296 | 296 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:296 | 296 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Lidocaine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:296 | 296 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0020 | 73271-0020-1 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:296 | 296 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-373 | 73693-373-01 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:297 | 297 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6412 | 71266-6412-3 | Mitomycin Bladder Instillation | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:297 | 297 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:297 | 297 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexamethasone Sodium Phosphate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:297 | 297 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-639 | 72833-639-30 | Dexpanthenol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:297 | 297 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0622 | 5446-0622-01 | Dexamethasone | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:297 | 297 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cisapride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:297 | 297 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclophosphamide | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:297 | 297 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8093 | 71285-8093-1 | Epinephrine | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:297 | 297 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-814 | 76154-814-15 | Epinephrine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:297 | 297 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-121 | 63037-121-25 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:297 | 297 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-104 | 69194-104-10 | Diltiazem Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:297 | 297 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8120 | 71266-8120-1 | Epinephrine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:297 | 297 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0035 | 81483-0035-0 | Epinephrine Bitartrate; Bupivacaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:297 | 297 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5311 | 26436-5311-1 | Epinephrine; Tetracaine; Lidocaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:297 | 297 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0022 | 73271-0022-1 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:297 | 297 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-376 | 73693-376-01 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:298 | 298 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-002 | 70713-002-01 | TESTOSTERONE SA2 100MG | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:298 | 298 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:298 | 298 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexamethasone Sodium Phosphate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:298 | 298 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2412 | 72627-2412-1 | Dexpanthenol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:298 | 298 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-776 | 69852-776-10 | Dexamethasone Acetate Anhydrous | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:298 | 298 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cisapride Monohydrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:298 | 298 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclophosphamide | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:298 | 298 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6624 | 71300-6624-2 | Epinephrine | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:298 | 298 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6030 | 71285-6030-1 | Epinephrine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:298 | 298 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-123 | 63037-123-25 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:298 | 298 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-615 | 68985-615-91 | Diltiazem Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:298 | 298 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:298 | 298 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0038 | 81483-0038-0 | Epinephrine Bitartrate; Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:298 | 298 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-127 | 82396-127-10 | Esmolol Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:298 | 298 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-144 | 70713-144-01 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:298 | 298 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-377 | 73693-377-01 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:299 | 299 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-027 | 73198-027-10 | BM-3 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:299 | 299 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Ketoprofen | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:299 | 299 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexamethasone Sodium Phosphate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:299 | 299 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexpanthenol | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:299 | 299 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexamethasone Sodium Phosphate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:299 | 299 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8700 | 71266-8700-1 | Cisatracurium Besylate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:299 | 299 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclophosphamide | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:299 | 299 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-507 | 65302-507-10 | Epinephrine | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:299 | 299 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8093 | 72196-8093-1 | Epinephrine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:299 | 299 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9035 | 71266-9035-5 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:299 | 299 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-117 | 63037-117-05 | Diltiazem Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:299 | 299 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:299 | 299 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0037 | 81483-0037-0 | Epinephrine Bitartrate; Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:299 | 299 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-145 | 70713-145-01 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:299 | 299 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-056 | 70713-056-01 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:299 | 299 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-370 | 73693-370-01 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:300 | 300 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-776 | 69852-776-10 | Dexamethasone Acetate 8 mg/mL | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:300 | 300 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Ketoprofen | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:300 | 300 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexamethasone Sodium Phosphate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:300 | 300 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexpanthenol; Pyridoxine; Thiamine Hydrochloride; Riboflavin; Niacinamide | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:300 | 300 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1050 | 71266-1050-2 | Dexamethasone Sodium Phosphate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:300 | 300 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Clopidogrel Bisulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:300 | 300 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclophosphamide | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:300 | 300 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-812 | 76154-812-15 | Epinephrine | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:300 | 300 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8120 | 71266-8120-1 | Epinephrine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:300 | 300 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1374 | 61141-1374-5 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:300 | 300 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-6015 | 60652-6015-1 | Diltiazem Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:300 | 300 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:300 | 300 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-121 | 73177-121-19 | Epinephrine Bitartrate; Tetracaine Hydrochloride; Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:300 | 300 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-148 | 70713-148-01 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:300 | 300 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-131 | 70713-131-01 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:300 | 300 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-144 | 70713-144-01 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:301 | 301 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-074 | 71506-074-05 | Ketamine Hydrochloride | 2025-2 | valid | 0 | 2026-09-18 |